These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17053827)

  • 41. [Sodium diphenylhydantoin as a probable cause of pancreatitis].
    Sepúlveda Vildósola AC; López Aguilar E; Yáñez López P; Ramírez Colorado R; Escobar Padilla B; Madrazo De la Garza A
    Rev Gastroenterol Mex; 1999; 64(4):186-9. PubMed ID: 10851582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol.
    Laghate VD; Gupta SB
    J Assoc Physicians India; 2004 Mar; 52():257-8. PubMed ID: 15636323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fanconi syndrome caused by antiepileptic therapy with valproic Acid.
    Knorr M; Schaper J; Harjes M; Mayatepek E; Rosenbaum T
    Epilepsia; 2004 Jul; 45(7):868-71. PubMed ID: 15230715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pancreatitis coincident with valproate and olanzapine use].
    Alonso-Alonso M; Rodríguez Prada JI; Gómez-Alonso J
    Neurologia; 2006; 21(1):47-8. PubMed ID: 16525929
    [No Abstract]   [Full Text] [Related]  

  • 46. Valproic acid-induced pancreatitis.
    Ben Salem C; Biour M; Hmouda H; Bouraoui A
    J Gastroenterol; 2007 Jul; 42(7):598-9. PubMed ID: 17653659
    [No Abstract]   [Full Text] [Related]  

  • 47. Pancreatic pseudocyst caused by valproic acid: case report and review of the literature.
    Queizán A; Hernández F; Rivas S
    Eur J Pediatr Surg; 2003 Feb; 13(1):60-2. PubMed ID: 12664419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Drug-induced acute pancreatitis: a personal contribution].
    Battillocchi B; Diana M; Dandolo R; Stefanini S; D'Amore L; Negro P
    Chir Ital; 2002; 54(5):605-12. PubMed ID: 12469456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Valproate induced parkinsonism].
    Park-Matsumoto YC; Tazawa T
    No To Shinkei; 1998 Jan; 50(1):81-4. PubMed ID: 9493204
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pancreatitis associated with valproic acid therapy.
    Batalden PB; Van Dyne BJ; Cloyd J
    Pediatrics; 1979 Oct; 64(4):520-2. PubMed ID: 114966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Valproate: Not All Boxed Warnings Are Created Equal.
    Wartman C; VandenBerg A
    Ann Pharmacother; 2022 Dec; 56(12):1349-1355. PubMed ID: 35392666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticonvulsant-induced chronic pancreatitis. A case report.
    Pezzilli R; Billi P; Melandri R; Broccoli PL; Fontana G
    Ital J Gastroenterol; 1992 Jun; 24(5):245-6. PubMed ID: 1623223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Three cases of Fanconi syndrome associated with valproate sodium treatment].
    Inoue T; Tanaka Y; Otani R; Itabashi H; Murakami N; Nagai T; Sakuta R
    No To Hattatsu; 2011 May; 43(3):233-7. PubMed ID: 21638910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Valproate teratogenicity and epilepsy syndrome.
    Bromfield EB; Dworetzky BA; Wyszynski DF; Smith CR; Baldwin EJ; Holmes LB
    Epilepsia; 2008 Dec; 49(12):2122-4. PubMed ID: 18557775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rhabdomyolysis and Hepatotoxicity From Valproic Acid: Case Reports.
    Walker CP; Deb S
    J Pharm Pract; 2021 Aug; 34(4):648-652. PubMed ID: 31658868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Valproic-acid-associated pancreatitis and hepatic toxicity in children with endstage renal disease.
    Levin TL; Berdon WE; Seigle RR; Nash MA
    Pediatr Radiol; 1997 Feb; 27(2):192-3. PubMed ID: 9028861
    [No Abstract]   [Full Text] [Related]  

  • 59. Pancreatitis during sodium valproate treatment.
    Williams LH; Reynolds RP; Emery JL
    Arch Dis Child; 1983 Jul; 58(7):543-4. PubMed ID: 6409011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Acceptability and tolerance of sodium valproate, a new sustained-action granule formulation, in monotherapy for epileptic children from 3 years old].
    Motte J; Pedespan JM; Sevestre M; Chiron C;
    Arch Pediatr; 2005 Oct; 12(10):1533-9. PubMed ID: 16099147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.